Both in Biotechnology
Immunovant vs ImmunityBio
Over the past year IMVT returned +36.6% and IBRX returned +224.4%; their daily moves had a correlation of 0.24.
IMVT +36.6% IBRX +224.4%Growth of $1, one year, split-adjusted
| Metric | IMVT | IBRX |
|---|---|---|
| Price | $29.27 | $8.63 |
| Market cap | $6.05B | $9.15B |
| Today | +1.35% | 0.00% |
| 1 month | −12.5% | −2.3% |
| 6 months | +8.6% | +24.0% |
| Year to date | +15.1% | +335.9% |
| 1 year | +36.6% | +224.4% |
| Revenue growth (YoY) | — | +93.9% |
| Gross margin | — | 99.4% |
| Net margin | — | −449.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 55.2× |
| Net cash | $797.8M | -$57.7M |
| Dividend yield | — | — |
| Volatility (60d) | 36.7% | 67.4% |
| Short % of float | 21.1% | 31.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).